Dr. Boulware is an infectious disease physician-scientist with formal training in clinical trials, public health, and tropical medicine. His primary research interests are in meningitis in resource-limited areas including diagnosis, prevention, treatment, and quality improvement initiatives incorporating cost-effectiveness analyses in order to translate knowledge into improved international standards of care. Dr. Boulware’s current research is focused on clinical trials for: 1) cryptococcal meningitis, which is the most common cause of adult meningitis in Africa, and 2) TB meningitis, the most deadly form of tuberculosis; 3) COVID-19, having led multiple outpatient clinical trials on prevention and therapeutic, most notably phase 3 trials on hydroxychloroquine disproving efficacy. Dr. Boulware has active research collaborations in Uganda, South Africa, Ethiopia, and Indonesia, leading a multidisciplinary, international research team.